A Randomized, Open-Label, Single-Dose, Three-Period Six-Sequence Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Vadadustat 450 mg and 150 mg Tablets and to Determine Food Effect on the 450 mg Vadadustat Tablet.
Phase of Trial: Phase I
Latest Information Update: 28 Mar 2019
Price : $35 *
At a glance
- Drugs Vadadustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Akebia Therapeutics
- 20 Mar 2019 Status changed from active, no longer recruiting to completed.
- 10 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 10 Sep 2018 New trial record